eXelate raised €12M in a Series B round in Aug 2010. The company is based in Israel. Investors in the round: Carmel Ventures. Data as of 6 Aug 2026.
No source on record — unverified.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
